scholarly journals Proteoform Analysis to Fulfill Unmet Clinical Needs and Reach Global Standardization of Protein Measurands in Clinical Chemistry Proteomics

2018 ◽  
Vol 38 (3) ◽  
pp. 487-497 ◽  
Author(s):  
Yuri E.M. van der Burgt ◽  
Christa M. Cobbaert
Author(s):  
Juergen Kratzsch ◽  
Nikola A. Baumann ◽  
Ferruccio Ceriotti ◽  
Zhong X. Lu ◽  
Matthias Schott ◽  
...  

Abstract Objectives Results can vary between different free thyroxine (FT4) assays; global standardization would improve comparability of results between laboratories, allowing development of common clinical decision limits in evidence-based guidelines. Content We summarize the path to standardization of FT4 assays, and challenges associated with FT4 testing in special populations, including the need for collaborative efforts toward establishing population-specific reference intervals. The International Federation of Clinical Chemistry and Laboratory Medicine Committee for Standardization of Thyroid Function Tests has undertaken FT4 immunoassay method comparison and recalibration studies and developed a reference measurement procedure that is currently being validated. Further studies are needed to establish common reference intervals/clinical decision limits. Standardization of FT4 assays will change test results substantially; therefore, a major education program will be required to ensure stakeholders are aware of the benefits of FT4 standardization, planned transition procedure, and potential clinical impact of the changes. Assay recalibration by manufacturers and approval process simplification by regulatory authorities will help minimize the clinical impact of standardization. Summary Significant progress has been made toward standardization of FT4 testing, but technical and logistical challenges remain. Outlook Collaborative efforts by manufacturers, laboratories, and clinicians are required to achieve successful global standardization of the FT4 assays.


2014 ◽  
Vol 3 (2) ◽  
pp. 153
Author(s):  
P Swathi ◽  
M Prasanth ◽  
MM Suchitra ◽  
AparnaR Bitla

2016 ◽  
Vol 60 (1) ◽  
pp. 27-30
Author(s):  
Masanori Seimiya ◽  
Yachiyo Endo ◽  
Mariko Watanabe ◽  
Haruna Asano ◽  
Saori Honda ◽  
...  
Keyword(s):  

1986 ◽  
Vol 14 (3) ◽  
pp. 146 ◽  
Author(s):  
F Vella
Keyword(s):  

2006 ◽  
Vol 26 (6) ◽  
pp. 2317-2326 ◽  
Author(s):  
Ivan del Barco Barrantes ◽  
Ana Montero-Pedrazuela ◽  
Ana Guadaño-Ferraz ◽  
Maria-Jesus Obregon ◽  
Raquel Martinez de Mena ◽  
...  

ABSTRACT dickkopf (dkk) genes encode a small family of secreted Wnt antagonists, except for dkk3, which is divergent and whose function is poorly understood. Here, we describe the generation and characterization of dkk3 mutant mice. dkk3-deficient mice are viable and fertile. Phenotypic analysis shows no major alterations in organ morphology, physiology, and most clinical chemistry parameters. Since Dkk3 was proposed to function as thyroid hormone binding protein, we have analyzed deiodinase activities, as well as thyroid hormone levels. Mutant mice are euthyroid, and the data do not support a relationship of dkk3 with thyroid hormone metabolism. Altered phenotypes in dkk3 mutant mice were observed in the frequency of NK cells, immunoglobulin M, hemoglobin, and hematocrit levels, as well as lung ventilation. Furthermore, dkk3-deficient mice display hyperactivity.


Sign in / Sign up

Export Citation Format

Share Document